Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening

Infection and Immunity

Volumn 76, Issue 4, 2008, Pages 1565-1571

  Aoshi, Taiki ^a   Nagata, Toshi ^a   Suzuki, Mina ^a   Uchijima, Masato ^a   Hashimoto, Dai ^a   Rafiei, Alireza ^a   Suda, Takafumi ^a   Chida, Kingo ^a   Koide, Yukio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; PROTEIN MPT 51; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BCG VACCINE; EPITOPE; HLA A ANTIGEN; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; MPT51 PROTEIN, MYCOBACTERIUM; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL SURFACE; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE GUN IMMUNIZATION; HUMAN; HUMAN CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING; TUBERCULIN TEST; TUBERCULOSIS; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; METABOLISM; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; INTERFERON TYPE II; MICE; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE LIBRARY; SPLEEN; TUBERCULOSIS;

EID: 42149093943     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01381-07     Document Type: Article

References (37)

1. Abou-Zeid, C., T. L. Ratliff, H. G. Wiker, M. Harboe, J. Bennedsen, and G. A. W. Rook. 1988. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun. 56:3046-3051.
2. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
3. Andersen, P., Å. B. Andersen, A. L. Sørensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
4. Baldwin, S. L., C. d'Souza, A. D. Roberts, B. P. Kelly, A. A. Frank, M. A. Lui, J. B. Ulmer, K. Huygen, D. M. McMurray, and I. A. Orme. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
5. Belisle, J. T., V. D. Vissa, T. Sievert, K. Takayama, P. J. Brennan, and G. S. Besra. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422.
6. + T lymphocytes. J. Infect. Dis. 186:991-998.
7. Charo, J., A. Geluk, M. Sundbäck, B. Mirzai, A. D. Diehl, K.-J. Malmberg, A. Achour, S. Huriguchi, K. E. van Meijgaarden, J.-W. Drijfhout, N. Beekman, P. van Veelen, F. Ossendorp, T. H. M. Ottenhoff, and R. Kiessling. 2001. The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur. J. Immunol. 31:3602-3611.
8. + T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 97:12210-12215.
9. +-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect. Immun. 72:2412-2415.
10. Falk, K., O. Rötzschke, S. Stevanorić, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296.
11. + T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int. Immunol. 14:925-934.
12. +-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. Infect. Immun. 70:2926-2932.
13. Geluk, A., V. Taneja, K. E. van Meijgaarden, E. Zanelli, C. Abou-Zeid, J. E. R. Thole, R. R. P. de Vries, C. S. David, and T. H. M. Ottenhoff. 1998. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95:10797-10802.
14. + T cells in HLA-transgenic mice and humans. J. Immunol. 165:6463-6471.
15. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. J. Exp. Med. 168:2045-2057.
16. Kaufmann, S. H. E. 2000. Is the development of a new tuberculosis vaccine possible? Nat. Med. 6:955-960.
17. Kaufmann, S. H. E. 2003. Immunity to intracellular bacteria, p. 1229-1261. In W. E. Paul (ed.), Fundamental immunology, 5th ed. Lippincott Williams & Wilkins Publishers, Philadelphia, PA.
18. Kaufumann, S. H. E., and J. L. Flynn. 2005. CD8 T cells in tuberculosis, p. 465-474. In S. T. Cole, K. D. Eisenach, D. N. McMurray, and W. R. Jacobs, Jr. (ed.), Tuberculosis and the tubercle bacillus. ASM Press, Washington, DC.
19. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.
20. Miki, K., T. Nagata, T. Tanaka, Y.-H. Kim, M. Uchijima, N. Ohara, S. Nakamura, M. Okada, and Y. Koide. 2004. Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51. Infect. Immun. 72:2014-2021.
21. Mohagheghpour, N., D. Gammon, L. M. Kawamura, A. van Vollenhoven, C. J. Benike, and E. G. Engleman. 1998. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161:2400-2406.
22. Ohara, N., H. Kitaura, H. Hotokezaka, T. Nishiyama, N. Wada, S. Matsu moto, T. Matsuo, M. Naito, and T. Yamada. 1995. Characterization of the gene encoding the MPB51, one of the major secreted protein antigens of Mycobacterium bovis BCG, and identification of the secreted protein closely related to the fibronectin binding 85 complex. Scand. J. Immunol. 41:433-442.
23. Pablos-Méndez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bnstreo, D. L. Cohn, C. S. B. Lanbregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis- drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
24. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
25. b β2m double knockout mice. J. Exp. Med. 185:2043-2051.
26. Ramalingam, B., K. R. Uma Devi, and A. Raja. 2003. Isotype-specific anti-38 and 27 kDa (mpt51) response in pulmonary tuberculosis with human immunodeficiency virus coinfection. Scand. J. Infect. Dis. 35:234-239.
27. Rammensee, H. G., J. Bachmann, N. P. N. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
28. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937.
29. Salter, R. D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TXB cell hybrid. EMBO. J. 5:943-949.
30. + CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165:7088-7095.
31. + T cells in mycobacterial infections. Immunol. Cell Biol. 78:325-333.
32. Sterne, J. A. C., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2:200-207.
33. Stuber, G., S. Modrow, P. Höglund, L. Franksson, J. Elvin, H. Wolf, K. Kärre, and G. Klein. 1992. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur. J. Immunol. 22:2697-2703.
34. b-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis. Infect. Immun. 72:3829-3837.
35. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648-661.
36. Wilson, R. A., W. N. Maughan, L. Kremer, G. S. Besra, and K. Fütterer. 2004. The structure of Mycobacterium tuberculosis MPT51 (FbpCl) defines a new family of noncatalytic α/β hydrolases. J. Mol. Biol. 335:519-530.
37. World Health Organization. 2007. WHO Report. 2007 Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/ global_report/2007/pdf/full.pdf. Accessed 21 August 2007.